DaVita HealthCare Partners Inc. 3rd Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DaVita (DVA) PT Trimmed to $90 at Piper Jaffray Post Q3; Maintains 'Overweight'
November 4, 2015 8:47 AM ESTPiper Jaffray analyst Kevin Ellich lowered his price target on DaVita (NYSE: DVA) to $90.00 (from $92.00) but maintained an Overweight rating.
Ellich commented, "While Q3 results beat Street estimates and HCP's operating income improved, DVA faces a number of potential headwinds that could reduce HCP's operating... More
DaVita (DVA) Tops Q3 EPS by 3c, Offers Outlook
November 3, 2015 4:40 PM ESTDaVita (NYSE: DVA) reported Q3 EPS of $1.00, $0.03 better than the analyst estimate of $0.97. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.46 billion.
Outlook
We are updating our consolidated operating income for 2015 to now be in the range of $1.870 billion to $1.915 billion.
Our... More
